In the context of cancer metastasis, the chemokine receptor CXCR4 has been observed to undergo upregulation and has been employed as a prognostic indicator in diverse cancer types, including leukemia, breast cancer, and PCa. This evidence concerns the gene CXCR4 and cancer.